White House: 8 Million People Signed Up for Health Insurance

Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act, the White House announced.

Antidepressants and Diabetes: Trust with Providers Needed for Adherence

Patients with diabetes who lack trust and shared decision-making with their providers are less likely to be adherent to antidepressant therapy for depression.

Indoor Tanning Tied to Unhealthy Weight Control Behavior

Adolescents who indoor tan, especially males, are more likely to exhibit unhealthy weight control behaviors.

Reduced Salt Intake Likely Dropped BP Levels in England

The reduction of dietary salt intake between 2003-2011 was likely an important contributor to decreases in blood pressure in the population of England.

Standard Ultrasound Criteria Needed in Carotid Artery Stenosis

Standardization of the diagnostic criteria defining the degree of carotid artery stenosis is needed for carotid duplex ultrasonography.

Leeches Help Save Woman's Ear

Although not a common procedure, the FDA approved the use of leeches in 2004 for amputation situations.

Cancer 'Vaccine' Passes Early Hurdle

Early progress has been made in developing a treatment that might one day help the immune system defend itself against cancer.

Legal Claims Rising for Laser Surgery by Nonphysicians

Legal claims related to cutaneous laser surgery performed by nonphysician operators are increasing, with most performed outside of a traditional medical setting.

FDA Approves Short Ragweed Pollen Allergen SL Tab

The FDA announced the approval of Ragwitek (Ambrosia artemisiifolia; Merck), the first sublingual allergen extract to treat short ragweed pollen induced allergic rhinitis, with or without conjunctivitis.

Arzerra Gains New Indication

The FDA has approved a new indication for Arzerra (ofatumumab; GlaxoSmithKline) to use in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL), for whom fludarabine-based therapy is considered inappropriate.